Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRKS00005615Phase 4Completed
Phase 4, randomised, open-label trial of calcitriol in diffuse non-toxic goiter and benign thyroid disease (2 arms), sponsored by Sana Klinikum Offenbach. Primary endpoint: Postoperative hypocalcaemia incidence. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on DRKS00005615.